Precancerous Condition: Clinical Trials

19 trials for Precancerous Condition, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 2 terminated, 1 unknown, 1 withdrawn. 19 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 319Completed 15, Terminated 2, Unknown 1, Withdrawn 1
Phase 21Withdrawn 1

Follow Precancerous Condition: new trials by email Literature Review of Precancerous Condition trials Research Report on Precancerous Condition

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
cetuximab, cisplatin, IMRT - Head and Neck Cancer, Precancerous Condition
Phase 3CompletedRadiation Therapy Oncology Group9872011-06-012026-07-20
Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia
clinical observation, infrared photocoagulation therapy - Anal Cancer, Neoplasm of Uncertain Malignant Potential
Phase 3CompletedAIDS Malignancy Consortium1202011-04-012020-08-04
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
rosuvastatin, placebo - Colorectal Cancer, Precancerous Condition
Phase 3TerminatedNSABP Foundation Inc4062010-03-012023-08-16
American Ginseng in Treating Patients With Fatigue Caused by Cancer
American ginseng, placebo - Chronic Myeloproliferative Disorders, Fatigue
Phase 3CompletedAlliance for Clinical Trials in Oncology3642008-10-012017-02-09
S0000D: Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000
Vitamin E, Selenium, Vitamin E placebo - Colorectal Cancer, Precancerous Condition
Phase 3CompletedSWOG Cancer Research Network80942008-06-012019-12-16
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
darbepoetin alfa, ferrous sulfate, sodium ferric gluconate complex in sucrose - Anemia, Leukemia
Phase 3CompletedMayo Clinic5022006-01-012011-05-17
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
educational intervention, Titrated pain management, questionnaire administration - Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders
Phase 3CompletedVanderbilt-Ingram Cancer Center982005-05-012012-09-06
A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia
Esomeprazole, Aspirin - Esophageal Cancer, Precancerous Condition
Phase 3CompletedUniversity of Oxford25572005-03-102025-05-01
Selenium for Prevention of Adenomatous Colorectal Polyps
Selenium - Colorectal Cancer, Adenomatous Colorectal Polyps
Phase 3TerminatedUniversity of Arizona16212005-01-202019-09-24
Diindolylmethane in Treating Patients With Abnormal Cervical Cells
oral microencapsulated diindolylmethane, polymerase chain reaction, cervical Papanicolaou test - Cervical Cancer, Precancerous Condition
Phase 3CompletedBarts and the London School of Medicine and Dentistry30002004-10-012013-08-07
Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants
human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine, hepatitis A inactivated virus vaccine - Cervical Cancer, Precancerous Condition
Phase 3CompletedGlaxoSmithKline74662004-06-302019-03-08
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
epoetin alfa - Anemia, Leukemia
Phase 3CompletedAlliance for Clinical Trials in Oncology3652003-06-012016-07-18
Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses
celecoxib, Placebo - Precancerous Condition
Phase 2 / Phase 3WithdrawnUniversity of Alabama at Birmingham2001-12-012013-08-05
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
ondansetron, placebo - Chronic Myeloproliferative Disorders, Leukemia
Phase 3CompletedAlliance for Clinical Trials in Oncology1002000-10-012016-07-06
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer
St. John's wort - Chronic Myeloproliferative Disorders, Fatigue
Phase 3CompletedMemorial Sloan Kettering Cancer Center1999-12-012013-01-18
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
epoetin alfa, placebo - Anemia, Breast Cancer
Phase 3CompletedAlliance for Clinical Trials in Oncology3441998-12-012016-07-13
Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps
placebo, eflornithine, sulindac - Precancerous Condition
Phase 3CompletedNational Cancer Institute (NCI)3751998-07-012015-01-22
T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum
liposomal T4N5 lotion - Precancerous Condition
Phase 3UnknownApplied Genetics301996-07-012013-11-06
Fenretinide in Treating Patients With Cervical Neoplasia
Fenretinide, Placebo - Cervical Cancer, Precancerous Condition
Phase 3CompletedM.D. Anderson Cancer Center391993-03-052018-10-24

Narrower conditions

Precancerous Conditions (19)  ·  Leukemia (7)  ·  Lymphoma (7)  ·  Multiple Myeloma (7)  ·  Neoplasms, Plasma Cell (7)  ·  Burkitt Lymphoma (5)  ·  Hodgkin Disease (5)  ·  Immunoblastic Lymphadenopathy (5)  ·  Immunoglobulin Light-chain Amyloidosis (5)  ·  Leukemia, Hairy Cell (5)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (5)  ·  Lymphoma, B-Cell, Marginal Zone (5)  ·  Lymphoma, Follicular (5)  ·  Lymphoma, Large B-Cell, Diffuse (5)  ·  Lymphoma, Large-Cell, Anaplastic (5)

Broader conditions

Neoplasms (19)  ·  Neoplasms by Site (14)  ·  Neoplasms by Histologic Type (11)  ·  Immune System Diseases (8)  ·  Blood Protein Disorders (7)  ·  Cardiovascular Diseases (7)  ·  DNA Virus Infections (7)  ·  Disease Attributes (7)  ·  Hematologic Diseases (7)  ·  Hemic and Lymphatic Diseases (7)  ·  Hemorrhagic Disorders (7)  ·  Hemostatic Disorders (7)  ·  Immunoproliferative Disorders (7)  ·  Infections (7)  ·  Lymphatic Diseases (7)

Interventions

Epoetin Alfa (2)  ·  Selenium (2)  ·  Asian ginseng (1)  ·  Aspirin (1)  ·  Celecoxib (1)  ·  Cetuximab (1)  ·  Cisplatin (1)  ·  Darbepoetin alfa (1)  ·  Deoxyribonuclease (Pyrimidine Dimer) (1)  ·  Early Intervention, Educational (1)  ·  Eflornithine (1)  ·  Esomeprazole (1)  ·  Fenretinide (1)  ·  Hypericum extract LI 160 (1)  ·  Light Coagulation (1)

Sponsors

Alliance for Clinical Trials in Oncology (4)  ·  AIDS Malignancy Consortium (1)  ·  Applied Genetics (1)  ·  Barts and the London School of Medicine and Dentistry (1)  ·  GlaxoSmithKline (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  NSABP Foundation Inc (1)  ·  National Cancer Institute (NCI) (1)  ·  Radiation Therapy Oncology Group (1)  ·  SWOG Cancer Research Network (1)  ·  University of Alabama at Birmingham (1)  ·  University of Arizona (1)  ·  University of Oxford (1)

Countries

United States (16)  ·  Canada (3)  ·  United Kingdom (2)  ·  Costa Rica (1)  ·  Germany (1)

Top investigators

M. Peter Lance, MD (2)  ·  Andy M. Trotti, MD (1)  ·  Charles L. Loprinzi, MD (1)  ·  Craig A. Elmets, MD (1)  ·  Daniel B. Yarosh, PhD (1)  ·  David J. Straus, MD (1)  ·  David P. Steensma, MD (1)  ·  Debra Barton, RN, PhD, AOCN, FAAN (1)  ·  Frank Meyskens (1)  ·  Janusz Jankowski, MD (1)  ·  Maura Gillison, MD, PhD (1)  ·  Michele Follen, MD, PhD (1)  ·  Nancy Wells, DNSc, RN (1)  ·  Norman Wolmark, MD (1)

Results publications

PMID 16505427, PMID 17699008, PMID 18378608, PMID 18948732, PMID 20197322, PMID 20538001, PMID 21115882, PMID 21865087, PMID 22850119, PMID 23060037, PMID 23834901, PMID 23873171, PMID 24014882, PMID 24958910, PMID 25018097, PMID 25057165, PMID 25139208, PMID 25796338, PMID 26071347, PMID 26346155, PMID 26467666, PMID 26892991, PMID 27519183, PMID 29718393, PMID 30060087, PMID 30449625, PMID 30899530, PMID 31299087, PMID 32214382, PMID 35017496, PMID 35709811, PMID 35815403, PMID 35842229, PMID 36401615, PMID 36999619, PMID 37040086, PMID 39961279, PMID 40796225, PMID 41343184, PMID 42658511

NIH funding

2004 (1), P01CA041108 (1), P30CA015083 (1), P30CA016672 (1), P30CA023074 (1), P30CA068485 (1), R01CA088078 (1), U01CA121947 (1), U10CA037429 (1)